Search

everythinglearnresearchcommunity

for

Search:↓

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Erectile dysfunction is linked to marital issues in patients with benign prostatic hyperplasia.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Statins do not impact BPH and LUTS progression when combined with finasteride.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Finasteride and dutasteride can affect sexual function in BPH patients.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.